Thursday, May 30, 2019

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv

No comments:

Post a Comment

New Jersey voter registration controversy explained: How 6,600 noncitizens got on the rolls, and what happens next

New Jersey Registered Voters News: New Jersey's Motor Vehicle Commission mistakenly registered thousands of noncitizens to vote. A softw...